September 16, 2025Pancreas

Syndecan-1 is a Key Mediator of Entosis and Cellular Competition in Pancreatic Cancer

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Research demonstrates that syndecan-1 enhances entotic activity in pancreatic cancer cells, suggesting implications for tumor aggressiveness.

Syndecan-1 facilitates entosis, enhancing tumor aggressiveness in pancreatic cancer.
High syndecan-1 expression correlates with increased entotic activity and decreased patient survival.
Immunohistochemistry and flow cytometry were utilized to assess syndecan-1's role in entosis.
These findings indicate syndecan-1 could be targeted therapeutically to disrupt entotic processes in pancreatic cancer.

Li et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Research demonstrates that syndecan-1 enhances entotic activity in pancreatic cancer cells, suggesting implications for tumor aggressiveness.